189 related articles for article (PubMed ID: 26961771)
21. The Impact of Insulin-Like Growth Factor Index and Biologically Effective Dose on Outcomes After Stereotactic Radiosurgery for Acromegaly: Cohort Study.
Graffeo CS; Donegan D; Erickson D; Brown PD; Perry A; Link MJ; Young WF; Pollock BE
Neurosurgery; 2020 Sep; 87(3):538-546. PubMed ID: 32267504
[TBL] [Abstract][Full Text] [Related]
22. Comparison of conventional external radiotherapy and stereotactic radiotherapy in the treatment of pituitary adenoma.
Puataweepong P; Dhanachai M; Dangprasert S; Laothamatas J; Theerapancharoen V; Yongvithisatid P
J Med Assoc Thai; 2009 Mar; 92(3):382-9. PubMed ID: 19301733
[TBL] [Abstract][Full Text] [Related]
23. Surgical and endocrinological outcomes in the treatment of growth hormone-secreting pituitary adenomas according to the shift of surgical paradigm.
Ku CR; Kim EH; Oh MC; Lee EJ; Kim SH
Neurosurgery; 2012 Dec; 71(2 Suppl Operative):ons192-203; discussion ons203. PubMed ID: 22743357
[TBL] [Abstract][Full Text] [Related]
24. Radiation treatment strategies for acromegaly.
Rowland NC; Aghi MK
Neurosurg Focus; 2010 Oct; 29(4):E12. PubMed ID: 20887122
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of CyberKnife radiosurgery for acromegaly.
Roberts BK; Ouyang DL; Lad SP; Chang SD; Harsh GR; Adler JR; Soltys SG; Gibbs IC; Remedios L; Katznelson L
Pituitary; 2007; 10(1):19-25. PubMed ID: 17273921
[TBL] [Abstract][Full Text] [Related]
26. The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma.
Losa M; Gioia L; Picozzi P; Franzin A; Valle M; Giovanelli M; Mortini P
J Clin Endocrinol Metab; 2008 Jul; 93(7):2546-52. PubMed ID: 18413424
[TBL] [Abstract][Full Text] [Related]
27. Giant GH-secreting pituitary adenomas: management of rare and aggressive pituitary tumors.
Shimon I; Jallad RS; Fleseriu M; Yedinak CG; Greenman Y; Bronstein MD
Eur J Endocrinol; 2015 Jun; 172(6):707-13. PubMed ID: 25792375
[TBL] [Abstract][Full Text] [Related]
28. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.
Edo N; Morita K; Suzuki H; Takeshita A; Miyakawa M; Fukuhara N; Nishioka H; Yamada S; Takeuchi Y
Endocr J; 2016 May; 63(5):469-77. PubMed ID: 26949262
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic radiotherapy for the treatment of pituitary adenomas.
Selch MT; Gorgulho A; Lee SP; Mattozo C; Solberg TD; Agazaryan N; Desalles AA
Minim Invasive Neurosurg; 2006 Jun; 49(3):150-5. PubMed ID: 16921455
[TBL] [Abstract][Full Text] [Related]
30. Target delineation and optimal radiosurgical dose for pituitary tumors.
Minniti G; Osti MF; Niyazi M
Radiat Oncol; 2016 Oct; 11(1):135. PubMed ID: 27729088
[TBL] [Abstract][Full Text] [Related]
31. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas.
Minniti G; Jaffrain-Rea ML; Osti M; Esposito V; Santoro A; Solda F; Gargiulo P; Tamburrano G; Enrici RM
Clin Endocrinol (Oxf); 2005 Feb; 62(2):210-6. PubMed ID: 15670198
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic radiosurgery for acromegaly.
Lee CC; Vance ML; Xu Z; Yen CP; Schlesinger D; Dodson B; Sheehan J
J Clin Endocrinol Metab; 2014 Apr; 99(4):1273-81. PubMed ID: 24471574
[TBL] [Abstract][Full Text] [Related]
33. Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission.
Pollock BE; Jacob JT; Brown PD; Nippoldt TB
J Neurosurg; 2007 May; 106(5):833-8. PubMed ID: 17542527
[TBL] [Abstract][Full Text] [Related]
34. Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa.
Maiza JC; Vezzosi D; Matta M; Donadille F; Loubes-Lacroix F; Cournot M; Bennet A; Caron P
Clin Endocrinol (Oxf); 2007 Aug; 67(2):282-9. PubMed ID: 17524029
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic Effect of Hypofractionated Stereotactic Radiotherapy Using CyberKnife for High Volume Cavernous Sinus Cavernous Hemangiomas.
Huang L; Sun L; Wang W; Cui Z; Zhang Z; Li J; Wang Y; Wang J; Yu X; Ling Z; Qu B; Pan LS
Technol Cancer Res Treat; 2019 Jan; 18():1533033819876981. PubMed ID: 31530156
[TBL] [Abstract][Full Text] [Related]
36. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic radiosurgery XVI: a treatment for previously irradiated pituitary adenomas.
Swords FM; Allan CA; Plowman PN; Sibtain A; Evanson J; Chew SL; Grossman AB; Besser GM; Monson JP
J Clin Endocrinol Metab; 2003 Nov; 88(11):5334-40. PubMed ID: 14602770
[TBL] [Abstract][Full Text] [Related]
38. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
Kreutzer J; Vance ML; Lopes MB; Laws ER
J Clin Endocrinol Metab; 2001 Sep; 86(9):4072-7. PubMed ID: 11549628
[TBL] [Abstract][Full Text] [Related]
39. CyberKnife radiotherapy for orbital metastases: A single-center experience on 24 lesions.
Riva G; Augugliaro M; Piperno G; Ferrari A; Rondi E; Vigorito S; Ciardo D; Orecchia R; Jereczek-Fossa BA
Eur J Ophthalmol; 2019 Jan; 29(1):61-68. PubMed ID: 29587486
[TBL] [Abstract][Full Text] [Related]
40. External radiotherapy of pituitary adenomas.
Zierhut D; Flentje M; Adolph J; Erdmann J; Raue F; Wannenmacher M
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):307-14. PubMed ID: 7673017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
